[ad_1]
the anticovid vaccine currently under study in the UK, it will hardly prevent everyone from getting infected, but could only alleviate the symptoms of the disease, is what British scientists and British government consultants say about the COVID emergency. As the Times reports, the scientists actually recalled that the same researchers at the University of Oxford, where one of the most promising vaccines is being studied, have set a minimum protection target that aims only to halve the number of cases. In practice, it is believed that the first generation of vaccines may be less effective than necessary to protect everyone and therefore should be containment measures maintained already in place as masks and social distancing.
Not even the anticovid vaccine, which for the British government may be ready in the first half of next year, might not be enough to return to normality. And precisely this was discussed in the last briefing between the government of Boris Johnson and the scientific advisers. In practice, government scientific consultants have warned that it will be necessary to evaluate how to explain to the country Caution is also needed when introducing the vaccine. for the coronavirus. “It seems that the most likely result in the short and medium term is to find a vaccine, or two doses of a vaccine, that only reduce the severity of symptoms,” a government source told the newspaper.
Professor Chris Whitty himself, the chief scientific adviser to the British executive, believes that science will eventually “come to the rescue”, but the first vaccines are unlikely to protect everyone and therefore the virus will continue to circulate. In particular, it is hypothesized that the vaccine may have a effectiveness rate between 40% and 60% – just like flu shots – and it is highly unlikely to completely prevent infection. To strengthen the effect of the vaccine, some experts believe that people may need a first dose and then a booster a month later to avoid contracting the virus. In this sense, the ongoing trials in the country are also moving where volunteers who had offered to participate in the trials were recently contacted to undergo a new dose of vaccine.
[ad_2]
